Skip to main content

eeDAP studies: Polling for T-con times and Pathology Informatics Update

First, I hope you are interested and ready for a T-con. Please visit this link to enter your times of availability

http://whenisgood.net/eeDAP1

 

Next, if you do nothing else, please make sure I have at least correctly identified the lead of each team at https://nciphub.org/groups/eedapstudies/wiki . Of course, I hope everyone will also consider updating their “Team and Objectives” page. Check out those of the “Ready” teams.

 

Last, I have been on the phone with Ul Balis about the Pathology Informatics conference. He wants the WSI WG meeting at the conference again (Sunday afternoon 5/21/17). We also discussed two additional ways to participate in the main conference. He offered me a presentation slot to discuss this eeDAP studies project and he offered a special poster opportunity. The special poster would include a table and power to set up an eeDAP system in the exhibit hall. I am planning on having my assistant man the table to demo the eeDAP system and organize *data collection* throughout the conference.

 

I hope all of you can come to the Sunday meeting. I hope some of you are interested in providing an update of your work either during the Sunday meeting or on a poster. I am sticking my neck out big time because I believe in this project.

 

Please visit the link to enter your times you are available for a T-con as soon as possible. We have a lot to talk about. Also, I am archiving emails at https://nciphub.org/groups/eedapstudies/blog

 

Brandon D. Gallas, PhD
Mathematician     

Center For Devices and Radiological Health
Office of Science and Engineering Laboratories
U.S. Food and Drug Administration

Tel: 301-796-2531
Brandon.Gallas@fda.hhs.gov



       

Excellent customer service is important to us. Please take a moment to provide feedback regarding the customer service you have received: https://www.research.net/s/cdrhcustomerservice?O=700&D=770&B=770&E=&S=E

 

 

Comments on this entry

There are no comments at this time.

Post a comment

You must log in to post comments.

Please keep comments relevant to this entry.

Line breaks and paragraphs are automatically converted. URLs (starting with http://) or email addresses will automatically be linked.